Confirmation trial for body fat-reducing effect of a beverage containing the lactic acid bacterial strain CP1563 - A randomized, double-blind, placebo-controlled parallel group trial -

Confirmation trial for body fat-reducing effect of a beverage containing the lactic acid bacterial strain CP1563 - A randomized, double-blind, placebo-controlled parallel group trial - - Trial for body fat-reducing effect of CP1563

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022842

Enrollment

200

Registered

2016-06-24

Start date

2016-06-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults with BMI values over 23 but less than 30

Interventions

Daily intakes of a beverage containing CP1563 for 18 weeks Daily intakes of a beverage without CP1563 for 18 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Subjects whose BMI values are over 23 but less than 30 (subjects of high normal and obesity class I) 2. Subjects whose visceral fat area is around 100 cm2

Exclusion criteria

Exclusion criteria: 1. Persons who take drugs for adiposity, hypertension and dyslipidemia 2. Persons who cannot give up the intake of possible supplements which may affect the status of fat, blood pressure and plasma lipids 3. Persons who cannot terminate the consumption of foods containing large number of lactic acid bacteria during the trial

Design outcomes

Primary

Measure	Time frame
Evaluate the effects of a beverage containing CP1563 on fat area determined by CT through the 18-week intervention period	—

Secondary

Measure	Time frame
Evaluate the effects of a beverage containing CP1563 on lipid and sugar metabolisms through the 18-week intervention period	—

Countries

Japan

Contacts

Public ContactYoshika Komori

KSO Co., Ltd Chairperson

yoshi@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026